메뉴 건너뛰기




Volumn 32, Issue 8, 2011, Pages

Periprocedural management of patients on dabigatran etexilate treatment

Author keywords

[No Author keywords available]

Indexed keywords

DABIGATRAN ETEXILATE; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

EID: 80052884591     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2731     Document Type: Letter
Times cited : (2)

References (4)
  • 1
    • 77952220109 scopus 로고    scopus 로고
    • Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation
    • Siddiqui FM, Qureshi AI. Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation. Expert Opin Pharmacother 2010;11:1403-11
    • (2010) Expert Opin Pharmacother , vol.11 , pp. 1403-1411
    • Siddiqui, F.M.1    Qureshi, A.I.2
  • 2
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51
    • (2009) N Engl J Med , vol.361 , pp. 1139-1151
    • Connolly, S.J.1    Ezekowitz, M.D.2    Yusuf, S.3
  • 3
    • 77953168824 scopus 로고    scopus 로고
    • Dabigatran etexilate: A novel, reversible, oral direct thrombin inhibitor - Interpretation of coagulation assays and reversal of anticoagulant activity
    • Epub 2010 Mar 29
    • van Ryn J, Stangier J, Haertter S, et al. Dabigatran etexilate: a novel, reversible, oral direct thrombin inhibitor-interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 2010;103:1116 -27. Epub 2010 Mar 29
    • (2010) Thromb Haemost , vol.103 , pp. 1116-1127
    • Van Ryn, J.1    Stangier, J.2    Haertter, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.